XML 13 R1.htm IDEA: XBRL DOCUMENT v3.25.1
Document and Entity Information - shares
3 Months Ended
Mar. 31, 2025
Apr. 30, 2025
Document and Entity Information    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Mar. 31, 2025  
Document Transition Report false  
Securities Act File Number 001-37581  
Entity Registrant Name Aclaris Therapeutics, Inc.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 46-0571712  
Entity Address, Address Line One 701 Lee Road, Suite 103  
Entity Address, City or Town Wayne  
Entity Address, State or Province PA  
Entity Address, Postal Zip Code 19087  
City Area Code 484  
Local Phone Number 324-7933  
Title of 12(b) Security Common Stock, $0.00001 par value  
Trading Symbol ACRS  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   108,281,239
Entity Central Index Key 0001557746  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2025  
Document Fiscal Period Focus Q1  
Amendment Flag false